XML 61 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Note 16 - Subsequent Event (Details Textual) - Subsequent Event [Member]
¥ in Thousands, $ in Thousands
Aug. 25, 2021
USD ($)
Aug. 25, 2021
CNY (¥)
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”) [Member] | Jiangsu Hengrui Pharmaceuticals Co., Ltd. [Member]    
Co-development Agreement, Up-front Payment to be Received $ 30,000 ¥ 200,000
Co-development Agreement, Maximum Regulatory and Sales Milestones to be Received $ 170,000 ¥ 1,100,000
Jiangsu Hengrui Pharmaceuticals Co., Ltd. [Member] | Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”) [Member]    
Investment Agreement, Percentage of Equity Interests for Cash Consideration 2.50% 2.50%
Investment Agreement, Consideration to be Paid $ 15,000 ¥ 100,000